KTC
BHC icon

Kistler-Tiffany Companies’s Bausch Health BHC Stock Holding History

Kistler-Tiffany Companies’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,339
Closed -$48K – 507
2016
Q4 		$48K Sell
3,339
-2,228
-40% -$40.9K 0.02% 254
2016
Q3 		$137K Buy
5,567
+2,719
+95% +$70.4K 0.07% 156
2016
Q2 		$57K Buy
2,848
+1,525
+115% +$43.2K 0.03% 236
2016
Q1 		$35K Buy
1,323
+208
+19% +$15.4K 0.02% 287
2015
Q4 		$113K Buy
1,115
+225
+25% +$25.3K 0.06% 180
2015
Q3 		$159K Sell
890
-85
-9% -$19.8K 0.1% 141
2015
Q2 		$217K Sell
975
-245
-20% -$54.3K 0.13% 111
2015
Q1 		$242K Hold
1,220
– – 0.15% 90
2014
Q4 		$175K Hold
1,220
– – 0.11% 118
2014
Q3 		$160K Hold
1,220
– – 0.11% 124
2014
Q2 		$154K Hold
1,220
– – 0.11% 122
2014
Q1 		$161K Hold
1,220
– – 0.12% 109
2013
Q4 		$143K Sell
1,220
-375
-24% -$41.1K 0.11% 119
2013
Q3 		$166K Hold
1,595
– – 0.13% 102
2013
Q2 		$137K Buy
+1,595
New +$126K 0.12% 114

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Kistler-Tiffany Companies's BHC Position: Q1 2017 in Review

Kistler-Tiffany Companies sold out of Bausch Health (BHC) in Q1 2017, closing a stake of 3,339 shares — an estimated $48K sold.

Kistler-Tiffany Companies first reported a position in BHC in Q2 2013 and held it in 15 quarters. The position peaked at $242K in Q1 2015. 327 funds tracked by Wall St. Rank hold BHC as of Q1 2017.

  • Kistler-Tiffany Companies reported no remaining Bausch Health position as of Q1 2017 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 3,339 Bausch Health shares in Q1 2017, an estimated $48K.
  • Kistler-Tiffany Companies first reported a position in Bausch Health in Q2 2013 and held it in 15 quarters.
  • Kistler-Tiffany Companies's Bausch Health position peaked at $242K in Q1 2015.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q1 2017.

Based on Kistler-Tiffany Companies's 13F filing for Q1 2017, filed 4 May 2017.